ANZHELIKA GRZESIAK: Open Payments
NPI 1790543932 · NORMAL, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,274 in 48 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $278 · 2025 $1,274
Food & beverage: $1,181Education: $93
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $478 |
| ABBVIE INC. | 14 | $369 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $173 |
| Aimmune Therapeutics, Inc. | 3 | $65 |
| Madrigal Pharmaceuticals | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Ardelyx, Inc. | 2 | $33 |
| Lilly USA, LLC | 1 | $28 |
| Novo Nordisk Inc | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
Products named: TREMFYA, SKYRIZI, ENTYVIO, RINVOQ, ZENPEP, EOHILIA, LINZESS, REZDIFFRA.
Industry payments across IL — which companies pay providers there.
